Systemic-exposure study of AN 2728 in patients with psoriasis.

Trial Profile

Systemic-exposure study of AN 2728 in patients with psoriasis.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2012

At a glance

  • Drugs Crisaborole (Primary)
  • Indications Psoriasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Feb 2012 Status changed from recruiting to completed, according to an Anacor Pharmaceuticals media release.
    • 07 Feb 2012 Results were reported in an Anacor Pharmaceuticals media release.
    • 22 Nov 2011 Results are expected in early 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top